All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Diurnal variation in cholesterol 7 alpha-hydroxylase activity is determined by the-203A > C polymorphism of the CYP7A1 gene

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F16%3A00060000" target="_blank" >RIV/00023001:_____/16:00060000 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11110/16:10324350

  • Result on the web

    <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856193/pdf/CroatMedJ_57_0111.pdf" target="_blank" >https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856193/pdf/CroatMedJ_57_0111.pdf</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3325/cmj.2016.57.111" target="_blank" >10.3325/cmj.2016.57.111</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Diurnal variation in cholesterol 7 alpha-hydroxylase activity is determined by the-203A > C polymorphism of the CYP7A1 gene

  • Original language description

    Aim To determine whether the promoter polymorphism -203A>C of cholesterol-7 alpha-hydroxylase encoding gene (CYP7A1) affects diurnal variation in CYP7A1 enzyme activity. Methods The study included 16 healthy male volunteers -8 homozygous for -203A and 8 homozygous for the -203C allele of CYP7A1. Three 15-hour examinations (from 7am to 10pm) were carried out for each of the participants: after one-day treatment with cholestyramine; after one-day treatment with chenodeoxycholic acid (CDCA); and a control examination without any treatment. The plasma concentration of 7 alpha-hydroxy-4-cholesten-3-one (C4), a marker of CYP7A1 activity, was determined in all the experiments at 90-min intervals. Results CYP7A1 activity was up-regulated after treatment with cholestyramine and suppressed after treatment with CDCA. There were no differences between -203A and -203C allele carriers in the response of enzyme activity to both drugs. In the control experiment, -203A allele carriers displayed diurnal variation in enzyme activity, whereas CYP7A1 activity did not change in -203C allele carriers. These results were confirmed by modeling the dynamics of C4 using polynomial regression. Conclusion The promoter polymorphism of the CYP7A1 gene has a pronounced impact on diurnal variation in CYP7A1 activity.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FB - Endocrinology, diabetology, metabolism, nutrition

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/NT13151" target="_blank" >NT13151: Cholesterol 7alpha-hydroxylase polymorphism as a predictor cholesterolemia responsiveness</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2016

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Croatian medical journal

  • ISSN

    0353-9504

  • e-ISSN

  • Volume of the periodical

    57

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    HR - CROATIA

  • Number of pages

    7

  • Pages from-to

    111-117

  • UT code for WoS article

    000377053400004

  • EID of the result in the Scopus database